Evidence map›Paper›PMID 32249098›Full record

ArticleJournal of visceral surgery2020

Strategy for the practice of digestive and oncological surgery during the Covid-19 epidemic.

J-J Tuech, A Gangloff, F Di Fiore, P Michel, C Brigand, K Slim, M Pocard, L Schwarz

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Journal of visceral surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04434261 (Oncological Surgery in Times of COVID-19), which is not on this map. Cited by 78 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 3 pooled it
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04434261 unknown statusnot on this map

Oncological Surgery in Times of COVID-19: Effectiveness of Preoperative Screening for Sars-Cov-2

TypeobservationalSponsorInstituto Brasileiro de Controle do CancerRan2020 to 2021Enrolled1,500ConditionsSARS-CoV-2, Oncology, SurgeryArmsPT-PCR test for SARS-CoV-2
3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 3 syntheses or guidelines pooled it, 141 citations in OpenAlex.

  1. Laparoscopic Surgery and the debate on its safety during COVID-19 pandemic: A systematic review of recommendations.The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland · 2021
    Pooled it
  2. Guideline
  3. COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR).Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · 2020
    Guideline
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Observational
  10. Observational
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Review
  17. ANMCO POSITION PAPER: cardio-oncology in the COVID era (CO and CO).European heart journal supplements : journal of the European Society of Cardiology · 2021
    Article
  18. Article
  19. Article
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

J-J TuechRouen University Hospital, Department of Digestive Surgery, 1, rue de Germont, 76031 Rouen cedex, France; Normandie University, UNIROUEN, UMR 1245 Inserm, Rouen University Hospital, Department of Genomic and Personalized Medicine in Cancer and Neurological Disorders, 76000 Rouen, France. Electronic address: jean-jacques.tuech@chu-rouen.fr.
A GangloffRouen University Hospital, Department of Digestive Oncology, 1, rue de Germont, 76031 Rouen cedex, France.
F Di FioreNormandie University, UNIROUEN, UMR 1245 Inserm, Rouen University Hospital, Department of Genomic and Personalized Medicine in Cancer and Neurological Disorders, 76000 Rouen, France; Rouen University Hospital, Department of Digestive Oncology, 1, rue de Germont, 76031 Rouen cedex, France.
P MichelNormandie University, UNIROUEN, UMR 1245 Inserm, Rouen University Hospital, Department of Genomic and Personalized Medicine in Cancer and Neurological Disorders, 76000 Rouen, France; Rouen University Hospital, Department of Digestive Oncology, 1, rue de Germont, 76031 Rouen cedex, France.
C BrigandDepartment of General and Digestive Surgery, Hautepierre Hospital, Strasbourg University Hospital, 67200 Strasbourg, France.
K SlimDepartment of digestive surgery, CHU Clermont-Ferrand, 63003 Clermont-Ferrand, France.
M PocardUniversité de Paris, UMR 1275 CAP Paris-Tech, 75010 Paris, France; Service de chirurgie digestive et cancérologique Hôpital Lariboisière, 2, rue Ambroise Paré, 75010 Paris, France.
L SchwarzRouen University Hospital, Department of Digestive Surgery, 1, rue de Germont, 76031 Rouen cedex, France; Normandie University, UNIROUEN, UMR 1245 Inserm, Rouen University Hospital, Department of Genomic and Personalized Medicine in Cancer and Neurological Disorders, 76000 Rouen, France.
Inserm · FRCentre Hospitalier Universitaire de Clermont-Ferrand · FRHôpital d'Hautepierre · FRParisTech · FRUniversité de Rouen Normandie · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Covid-19 pandemic is changing the organization of healthcare and has a direct impact on digestive surgery. Healthcare priorities and circuits are being modified. Emergency surgery is still a priority. Functional surgery is to be deferred. Laparoscopic surgery must follow strict rules so as not to expose healthcare professionals (HCPs) to added risk. The question looms large in cancer surgery-go ahead or defer? There is probably an added risk due to the pandemic that must be balanced against the risk incurred by deferring surgery. For each type of cancer-colon, pancreas, oesogastric, hepatocellular carcinoma-morbidity and mortality rates are stated and compared with the oncological risk incurred by deferring surgery and/or the tumour doubling time. Strategies can be proposed based on this comparison. For colonic cancers T1-2, N0, it is advisable to defer surgery. For advanced colonic lesions, it seems judicious to undertake neoadjuvant chemotherapy and then wait. For rectal cancers T3-4 and/or N+, chemoradiotherapy is indicated, short radiotherapy must be discussed (followed by a waiting period) to reduce time of exposure in the hospital and to prevent infections. Most complex surgery with high morbidity and mortality-oesogastric, hepatic or pancreatic-is most often best deferred.

Indexed as

Coronavirus InfectionsPandemicsPneumonia, ViralCOVID-19Digestive System DiseasesDigestive System NeoplasmsHealth Services Needs and DemandHumansLaparoscopyPostoperative CarePractice Guidelines as TopicTime-to-TreatmentCancerCoronavirusCovid-19Digestive surgerySurgical complications

Identifiers

PMID32249098
PMCPMC7269902
OpenAlexW3047888040

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.